Innovace 10 mg tablets
Authorisation PA23198/005/003 · Organon Pharma (Ireland) Limited
- Licence holder
- Organon Pharma (Ireland) Limited (all products →)
- Active substance
- Enalapril maleate
- Clinical trials
- 5 clinical trials →
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC codes
- C09AA, C09AA02
- First authorised
- 16/09/1985
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Enalapril maleate: supply and approvals
27 authorised products on the HPRA list contain Enalapril maleate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 41 years (since 16 September 1985). The HPRA list marks it as marketed in Ireland.
Other medicines with Enalapril maleate in Ireland
26 other products on the HPRA list contain Enalapril maleate, from 9 licence holders; 14 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| ENAP 10 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| ENAP 20 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| ENAP 5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Enalapril maleate Accord 10 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Enalapril maleate Accord 20 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Enalapril maleate Accord 5 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Enalapril/Lercanidipine Krka 10 mg/10 mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Enalapril/Lercanidipine Krka 20 mg/10 mg film-coated tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Innovace 2.5 mg Tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Innovace 20 mg tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Innovace 5 mg tablets | Organon Pharma (Ireland) Limited | National authorisation (PA) | Marketed |
| Lercaril 10 mg/10 mg film-coated tablets | Recordati Ireland Limited | National authorisation (PA) | Marketed |
Other substances in ATC group C09AA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 9 other active substances share the group C09AA with this product:
Ramipril (19) · Lisinopril Dihydrate (9) · Perindopril tert-butylamine (6) · Lisinopril (4) · Perindopril arginine (3) · Lisinopril (as dihydrate) (2) · Trandolapril (2) · Perindopril tosilate (2) · Zofenopril calcium (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Organon Pharma (Ireland) Limited holds 55 products on the HPRA list, with 22 different active substances; 42 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.